Publications
Detailed Information
Prognostic Significance of HLA Class I Expressing in Gastric Carcinoma Defined by Monoclonal Anti-Pan HLA Class I Antibody, EMR8-5
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Hae-Wan | - |
dc.contributor.author | Min, Soo Kee | - |
dc.contributor.author | Ju, Young-Su | - |
dc.contributor.author | Sung, Joohon | - |
dc.contributor.author | Lim, Man Sup | - |
dc.contributor.author | Yang, Dae Hyun | - |
dc.contributor.author | Lee, Bong Hwa | - |
dc.date.accessioned | 2023-07-14T04:31:31Z | - |
dc.date.available | 2023-07-14T04:31:31Z | - |
dc.date.created | 2021-10-22 | - |
dc.date.issued | 2011-08 | - |
dc.identifier.citation | Journal of Gastrointestinal Surgery, Vol.15 No.8, pp.1336-1343 | - |
dc.identifier.issn | 1091-255X | - |
dc.identifier.uri | https://hdl.handle.net/10371/195179 | - |
dc.description.abstract | Downregulation or loss of HLA class I molecules has been demonstrated in human cancers. The aim of this study was to assess the clinical significance of HLA class I expression in gastric cancer. Gastric cancer tissues from 189 patients were examined for expression of HLA class I heavy chain antigens by immunohistochemical staining with EMR8-5. The expression level of HLA class I of tumor cells is categorized by combining an estimate the percentage of immunoreactive cell with an estimate of the staining intensity. The relationship between HLA class I expression and clinicopathologic parameters, patient survival, and tumor recurrence were analyzed. HLA class I was downregulated in 85 (45.0%) of the gastric carcinomas. Staining revealed 104 (55.0%) tumors with strongly positive expression of HLA class I antigens, 76 (40.2%) tumors with weakly positive expression, and 9 (4.8%) tumors with negative expression. The expression of HLA class I antigen did not correlate with any other clinicopathologic parameters. Moreover, HLA class I expression was neither a risk factor for tumor recurrence nor survival. The downregulation of HLA class I expression is not associated with patient prognosis. | - |
dc.language | 영어 | - |
dc.publisher | Springer Verlag | - |
dc.title | Prognostic Significance of HLA Class I Expressing in Gastric Carcinoma Defined by Monoclonal Anti-Pan HLA Class I Antibody, EMR8-5 | - |
dc.type | Article | - |
dc.identifier.doi | 10.1007/s11605-011-1545-3 | - |
dc.citation.journaltitle | Journal of Gastrointestinal Surgery | - |
dc.identifier.wosid | 000293243200013 | - |
dc.identifier.scopusid | 2-s2.0-79960848138 | - |
dc.citation.endpage | 1343 | - |
dc.citation.number | 8 | - |
dc.citation.startpage | 1336 | - |
dc.citation.volume | 15 | - |
dc.description.isOpenAccess | N | - |
dc.contributor.affiliatedAuthor | Sung, Joohon | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.subject.keywordPlus | SQUAMOUS-CELL CARCINOMA | - |
dc.subject.keywordPlus | DOWN-REGULATION | - |
dc.subject.keywordPlus | ALLELE FREQUENCIES | - |
dc.subject.keywordPlus | MALIGNANT-CELLS | - |
dc.subject.keywordPlus | CANCER | - |
dc.subject.keywordPlus | MOLECULES | - |
dc.subject.keywordPlus | ASSOCIATION | - |
dc.subject.keywordPlus | IMMUNOTHERAPY | - |
dc.subject.keywordPlus | ABNORMALITIES | - |
dc.subject.keywordPlus | MECHANISMS | - |
dc.subject.keywordAuthor | Gastric cancer | - |
dc.subject.keywordAuthor | Human leukocyte antigen class I | - |
dc.subject.keywordAuthor | Immunohistochemistry | - |
- Appears in Collections:
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.